Latest Products
The medical device industry will see more development opportunities next year.
2019-12-23
Recently, at the 2019 Industrial Annual Conference of the China Medical Device Industry Association, Tang Min, a member of the State Council's Counselor and the China 50 Economists Forum, interpreted the recently released "Communiqué of the 2019 Central Economic Work Conference" (hereinafter referred to as the "Communiqué"), indicating that the global economy will slow down sharply next year, and the domestic economic situation also emphasizes "stability." However, judging from the new spirit and new proposals in the Communiqué, the medical device industry, as an advanced manufacturing industry and a sector related to people's livelihood, still has more and better opportunities. 1. "Stability" is the top priority; there will be many difficulties next year. After the release of the Communiqué, some people specifically counted the number of times the word "stable" appeared.
This plan injects new vitality and impetus into Yunnan Province's medical device industry
2019-12-20
On December 20, the "Yunnan Province Medical Device Registrant System Pilot Implementation Plan" (hereinafter referred to as the "Plan"), formulated by the Yunnan Provincial Drug Supervision and Administration Bureau, will be officially implemented. The introduction of the Plan is an important measure to optimize the allocation of medical device resources in Yunnan Province, further unleash the vitality of the industry, accelerate the construction of the China (Yunnan) Pilot Free Trade Zone, and promote the innovative development of the medical device industry in Yunnan Province.
Why was the Plan introduced?
Hu Yu, Deputy Director of the Provincial Drug Administration Bureau, introduced that the medical device registrant system is a system where the applicant for medical device registration submits an application for marketing authorization of medical devices, and the samples are entrusted to contract manufacturing enterprises for production.
2019-12-19
On December 12, the "China-Foreign Medical Device Enterprise Exchange Roundtable," hosted by the China Chamber of Commerce for Import and Export of Medicines and Health Products, was successfully held in Beijing. Vice President Meng Dongping, Vice Director Wang Shucai of the Medical Device Supervision Department of the National Medical Products Administration, and Director Lin Senyong of the Medical Device Supervision Office of the Shanghai Municipal Drug Administration attended the meeting and delivered speeches. The meeting invited more than 40 representatives from 23 domestic and foreign medical device companies, including the Shanghai Medical Device Industry Association, Guoyao Medical Devices, United Imaging Healthcare (Shanghai), Mindray (Shenzhen), GE, Philips, Siemens, Johnson & Johnson, Medtronic, Abbott, Olympus, B. Braun, and Varian. The meeting was chaired by Vice Secretary-General Cai Tianzhi. Meeting site
Frequent medical device recalls: What's happening with Johnson & Johnson?
2019-12-18
On December 6, the National Medical Products Administration (NMPA) issued an announcement that Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. initiated a recall of 2,585 units of the USSⅡPolyaxial multi-axial pedicle screw fixation system, which it distributes. However, prior to this, Johnson & Johnson has experienced a series of recalls of medical devices and contact lenses, including some classified as Class I recalls, representing the most serious level of risk, leading to industry questioning. Frequent recalls of Johnson & Johnson medical devices and contact lenses In addition to the recall on December 6, 2019, Johnson & Johnson initiated recalls every few months: On November 28, Johnson & Johnson initiated a recall of diagnostic/ablation
2019-12-17
Wuxi Xiangsheng Medical Technology Co., Ltd. focuses on the research, development, manufacturing, and sales of ultrasound medical imaging equipment, providing various ultrasound medical imaging equipment and professional technical development services with complete independent intellectual property rights to medical institutions, research institutions, and strategic partners at home and abroad. The company has gradually made breakthroughs in the technological research and development of three-dimensional breast ultrasound volume imaging systems, high-end cardiac ultrasound diagnostic systems based on artificial intelligence, new material probes, and low-power portable ultrasound diagnostic systems, breaking the monopoly of foreign products in the field of high-end specialized ultrasound technology. According to the different economic development levels of various countries in the world, the company launches
A staggering 71.43% share! Why are medical device companies flocking to the STAR Market?
2019-12-16
Since the launch of the STAR Market in July this year, less than half a year has passed, and 65 companies have already been listed on the STAR Market, of which 14 are pharmaceutical and biological companies, accounting for 21.54%. Among the 14 pharmaceutical and biological companies, medical devices have been particularly successful, with 10 companies, accounting for 71.43%. Chart 1 shows the situation of pharmaceutical and biological companies on the STAR Market. Data Source: iFind, Zhongkang Industrial Capital Research Center. Looking at these 14 pharmaceutical and biological companies, their financial data in 2019Q3 performed well, with four companies exceeding their operating income.
2019-12-12
Medical devices have become one of the most prominent industries in China's high-tech sector, with new products constantly emerging and product quality continuously improving. Mobile medical devices, precision medicine, and big data-based products are developing rapidly. Wang Shucai, Deputy Director of the Medical Device Supervision Department of the National Medical Products Administration, made these remarks at the 2019 Huaihai Biopharmaceutical Industry Development Summit. Medical devices involve nearly 100 disciplines, including acoustics, optics, electricity, magnetism, and mechanics, demonstrating extensive interdisciplinary collaboration and making it a recognized high-tech intensive industry. The US, EU, and Japan are all powerful players in the medical device industry, with the US and EU accounting for nearly 70% of the global market.